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A 66 year-old woman with a history of Raynaud’s phenomenon for 30 years, presented with fingertip 
calcification and ulceration. She complained of discharge of small stones from these ulcerated lesions for 
several years and  dysphagia in the past year. On physical examination, we noticed mild telangiectasias on 
her face. Calcifications were observed on her foot and hand radiographs. Laboratory findings revealed 
normal Ca++ and PO4, but the serum parathyroid hormone level was elevated on two occasions. 
Anticentromer antibody and ANA were positive, whereas anti-ScI 70 was negative. At gastroscopy, 
esophageal aperistaltism was found and esophagogastroduedonography(EGDG) was suggested. Esophageal 
dysmotility was found in EGDG and with these findings we decided the patient had CREST syndrome. 
Hyperparathyroidism was thought to be secondary to calcinosis cutis. We know that during the progression 
of this disease, the calcinosis type of systemic sclerosis can be characterized by renal involvement and 
secondary hyperparathyroidism, but it is rarely seen with the CREST syndrome. Because the CREST 
syndrome is a slowly progressing disease, we believe hyperparathyroidism in this patient developed after 
many years of hypertension due to the renal disease. 
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Otuz yıldır Raynaud's fenomeni tanısı olan 66 yaşındaki kadın hasta, parmak uçlarında kalsifikasyon ve 
ülserasyon şikayeti ile başvurdu. Bu ülsere bölgelerden küçük taşların koparak düştüğünü ifade ediyordu. 
Son yıllarda disfaji şikayeti de gelişen hastanın fizik muayenesinde yüzünde telenjiaktazileri mevcuttu.El ve 
ayak grafilerinde kalsifikasyonlar gözlendi. Kan tetkiklerinde kalsiyum ve fosfor düzeyleri normal ancak 
iPTH yüksekti. Anti-Scl 70 antikoru negatif iken ANA ve Anti-sentromer antikoru pozitif bulundu. 
Gastroskopisinde ösefagial aperistaltizm gözlendi ve Ösefagus-Mide-Duedonum(ÖMD) grafisi planlandı. 
ÖMD'de ösefagial dismotilitenin varlığı, hastada CREST sendromu olduğunu kanıtlıyordu. 
Hiperparatiroidinin ise kalsinozise ikincil geliştiği düşünüldü. Progresif Sistemik Sklerozisin kalsinozis 
tipinde böbrek tutulumu ve sekonder hiperparatiroidi geliştiği bilinmektedir. Ancak CREST sendromu çok 
yavaş ilerleyen bir hastalık olduğundan sekonder hiperparatiroidizm çok nadiren görülür. Vakamız bu açıdan 
nadir görülen, böbrek tutulumu ve hipertansiyon ile giden CREST sendromu olarak değerlendirildi. 
 




CREST syndrome is a limited type of 
scleroderma which includes Calcinosis cutis, 
Raynaud’s phenomenon, Esophageal 
dysfunction, Sclerodactyly and 
Telangiectasia. Patients with CREST 
syndrome are typically women and are older 
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than patients with systemic scleroderma (SSc) 
with a long history (10-15 years) of 
Raynaud’s phenomenon; skin involvement is 
limited to the digits or hands, face, feet and 
forearms; nail fold capillary dilatation; and 
early onset of facial and digital 
telangiectasias. Also, there is a high incidence 
(70-80%) of anticentromere antibodies (ACA) 
in CREST, whereas Scl-70 is more frequently 
associated with SSc1. 
 
Renal involvement and secondary 
hyperparathyroidism has previously been 
reported, mostly in SSc, but can also rarely 
occur in the CREST syndrome2 which is 
known as “scleroderma renal crisis” or 
“scleroderma kidney”. J.Serup and H.K. 
Hagdrup3 reported that secondary 
hyperparathyroidism is common in patients 
with aberrant calcifications as a regulatory 
mechanism to maintain a normal calcium 
concentration in the blood. But there were no 
differences in the levels of total calcium, 
phosphate, magnesium, alkaline phosphatase, 





We report a 66-year-old woman who had 
initially presented with Raynaud’s 
phenomenon 30 years previously. Her 
complaint  usually   occurred       on cold days 
or in cold water, initially presenting as pale 
and cold digits which progressed to painful, 
purple finger tips. In the last 10 years, first 
she  began having fingertip ulcerations and 
perforations, then the same symptoms began 
in her toes. She  noticed that some small 
things like stones came out of  these very 
painful ulcerations, which healed slowly. In 
addition, she  complained of dysphagia and 
heartburn in the last year. The patient had had 
hypertension for 5 years regulated with 
Verapamil at 120 mg /day. 
 
On physical examination, her blood pressure 
was 150/90 mmHg, and her heart rate was 94/ 
min. Skin hardness and thickening were 
palpated at the volar faces of the hands and 
toes. There was a hard, hyperkeratotic, round 
lesion (0.5cm in diameter) on the left hand 
third phalanx volar face and another round 
hyperkeratotic lesion (1 cm in diameter) on 
the left foot first phalanx volar face,from 
which the patient reported that a small stone 
and suppuration had recently discharged 
(Figure 1). In addition, we noticed clubbing 
and flexion-like shape deformation of the 
























Radiographs of bilateral hand and foot 
showed remarkable cutaneous calcifications, 
especially near the fingertips (Figure 2). On 
skin biopsy; epidermal hyperkeratosis, 
irregular acantosis and connective tissue 
increment in the dermis were seen. A deep 
biopsy performed from the calcinosis seen in 
the left hand radiogram   revealed 
calcification. 
 
In laboratory findings, the Ca++ level was 
mildly elevated  once (10.6mg/dl) but on 
follow-up turned to normal levels. Alkaline 
phosphatase and PO4 levels were in normal 
ranges. The parathyroid hormone was 
checked for differentiation of calcinosis cutis 
and was found to be high (218.4pg/ml, 15-65 
pg/ml normal ranges) on two occasions. Mg 
was mildly high (2.6 and 2.8mg/dl; 1.8-2.5 
normal ranges), CRP and Romatoid Factor 
(RF) were positive; ESR was 31mm/h. Blood 
urea level was elevated (45.5 mg/dl; 12.6-42.6 
Figure 1: Round hyperkeratotic lesion at
the left foot first phalanx volar face 
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normal ranges) but creatinin level was 
normal. According to these findings, we 
suspected the patient had CREST syndrome 
or systemic scleroderma. As we expected, the 
anti-centromere antibody and anti-nuclear 
antibody (ANA) were positive, whereas anti-


























We thought that hyperparathyroidism could 
have developed secondary to calcium 
deposition or to primary hyperparathyroidism, 
thus we tested 24 hour urine Ca++ and 
creatinine clearance. Urine Ca++ was normal 
(121mg/d; normal ranges 100-300mg/d) but 
creatinine clearance was found low (31ml/dk). 
These results led us to the conclusion that 
hyperparathyroidism may have been 
secondary to renal failure, which can be renal 
involvement due to the CREST syndrome. 
 
We planned a gastroscopy and 
eosephagogastroduedonography (EGD) 
because of dysphagia. In gastroscopy, 
aperistaltic eosephagus, hiatal hernia and 
pyloric dysfunction were found. In EGD, 
eosephageal dysmotility was observed. 
 
In conclusion, we decided that this patient had 
CREST syndrome. We know that in the 
CREST syndrome, pulmonary hypertension 
and biliary cirrhosis may appear, so an 
echocardiography was performed and 
pulmonary pressure was found in the normal 
range. In the laboratory findings, no problem 
with hepatic function appeared. As treatment 
for CREST, the patient was put on 100mg/day 
D-Penisillamine and 30mg/day Nifedipin. 
 
The patient was informed about this rare 
disease and an informed consent form was 




Calcification of the skin may occur in all 
forms of SSc, but is most commonly seen as 
part of the CREST syndrome. Generally, 
dystrophic calcification associated with 
massive collagen degeneration results in 
calcinosis4. The mineral deposits in 
dystrophic calcinosis cutis secondary to the 
CREST syndrome have been identified as 
amorphous calcium hydroxy-apatite5,6. The 
pathogenesis of calcinosis is not well 
understood, but the calcium can ulcerate the 
skin, be expelled as chalky material and cause 
recurrent episodes of local inflammation7. 
This calcification is associated with an 
underlying tissue abnormality and collagen 
degeneration allows increased intracellular 
calcium influx8. 
 
The calcinosis type of systemic sclerosis is 
characterized by secondary 
hyperparathyroidism developed during the 
progression of the disease. Secondary 
hyperparathyroidism is common in systemic 
sclerosis, in particular in patients with 
aberrant calcifications, usually with normal 
calcium and phosphate plasma levels. During 
the disease, in order to maintain a normal 
calcium concentration in the blood, secondary 
hyperparathyroidism develops3. 
 
Progressive systemic sclerosis is frequently 
associated with renal involvement. This 
complication is characterized by the sudden 
onset of severe arterial hypertension and 
untreated hypertension is followed by rapidly 
progressive oliguric renal failure 
(“scleroderma kidney” or “scleroderma renal 
crisis”)9. But such extensive changes are 
Figure 2: Cutaneous calcifications
(arrows) near the first fingertip of the
left   hand on the radiogram 
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unusual in patients with the CREST 
syndrome. 
 
Steen VD et al2 found that 18% of the patients 
having systemic scleroderma and only 1% of 
the patients who classified as having the 
CREST syndrome variant at the time of onset 
of “scleroderma renal crisis”. All these 
persons had telangiectasiae but not calcinosis 
of the fingers. In most patients, renal crisis 
developed early during their illness and no 
patient with renal disease had a serum 
creatinine value greater than 1.3mg/dl. 
According to this study, isolated mild 
hypertension does not serve to predict 
subsequent development of “scleroderma 
kidney” and is probably not etiologically 
related to the renal vascular abnormalities of 
progressive systemic sclerosis. But  there is 
still some disagreement concerning the 
frequency of arterial hypertension in patients 
with progressive systemic sclerosis and the 
question of whether or not this finding alone 
comprises evidence of renal involvement. 
 
Four months after the beginning of the 
treatment, the calcium ion level had returned 
to normal ranges in our patient. Some of the 
patient’s complaints had decreased. This led 
us to believe that hypercalcemia was related 
to the CREST syndrome and had developed in 
consequence of secondary 
hyperparathyroidism. Mild hypermagnesemia  
continued although we could not find any 
reason or relation to the disease. 
 
We did not perform a renal biopsy on the 
patient but we found some laboratory findings 
which supported probable renal involvement, 














This case may be an important guide 
concerning the follow-up of patients with the 
CREST syndrome, which is rarely seen 
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